Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acasti Pharma Inc (ACST.VN)

Acasti Pharma Inc (ACST.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acasti Pharma Inc 3009 Boulevard de la Concorde East Suite 102 Laval QC H7E 2B5 CAN

https://www.acastipharma.com P: 450-686-4555 F: 450-686-2505

Description:

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.

Key Statistics

Overview:

Market Capitalization, $K 25,429
Shares Outstanding, K 44,613
Annual Sales, $ 0 K
Annual Net Income, $ -42,429 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,391 K
60-Month Beta 1.44
% of Institutional Shareholders 0.04%

Growth:

1-Year Return -62.82%
3-Year Return -84.57%
5-Year Return -94.82%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date 02/13/24
Earnings Per Share ttm -0.34
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 08/31/21

ACST.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.05%
Return-on-Assets % -40.18%
Profit Margin % 0.00%
Debt/Equity 0.01
Price/Sales N/A
Price/Book 0.19
Book Value/Share 2.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar